Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers

Clinical trial NCT02423590 · UNKNOWN

Trial details

NCT number: NCT02423590
Sponsor: Queen Mary University of London
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Lung Cancer

Start date: 2014-06-01
Primary completion: 2018-05-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.